Specialty Pharmacy

Onduo use technological advances to enhance management of diabetes.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Canagliflozin with extended release formulation of metformin improves blood glucose control in type 2 diabetes.

Clinical practice guidelines created for the treatment and diagnosis of lymphangioleiomyomatosis (LAM).

How to evaluate quality in pharmacies that offer distinct services to complex disease states, such as HIV, hemophilia, and oncology.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Pevonedistat, currently being tested in clinical trials, shows promise in killing melanomas and other cancer types.

An individual’s life expectancy after initiating therapy differs among high and middle/low-income countries.

Top news of the day from across the health care landscape.

Exondys 51 granted accelerated approval to treat Duchenne muscular dystrophy.

Focus on the early stages of chronic obstructive pulmonary disease could prevent long-term lung function loss.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.

Top news of the day from across the health care landscape.

New strategy helps slow kidney disease progression that can occur in diabetes.

New insights pave the way for future treatment developments of pancreatic ductal adenocarcinoma.

HIV Test-and-Treat initiates antiretroviral therapy promptly, but may be too expensive to employ nationwide.

Top news of the week in oncology, and cancer drug development.

New mouse study suggests that exposure to endocrine disrupting chemicals may cause resistance to tamoxifen therapy in some breast cancers.

Ocrelizumab (Ocrevus) may improve treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.

With few advancements in treatment options, a new immunotherapy treatment could lead to better outcomes in pancreatic cancer.

Top news of the day from across the health care landscape.

Some individuals produce antibodies that can recognize HIV.

Mice treated with drugs that block a dopamine receptor inhibited cancer growth.

Top stories of the week from Specialty Pharmacy Times.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

New findings demonstrating differing mechanisms may contribute to a better understanding of acquired resistance to combination drug treatment in cancer.

A streamlined process for drug manufacturing may reduce prescription medication costs.

High body mass index linked to 10 types of cancer, including cancers of the breast, bowel, esophageal, and womb.